<;P>;PROBLEM TO BE SOLVED: To provide a new pharmaceutical based on the function of an LRG (Leucine Rich &alpha;2 Glycoprotein) by elucidating the function of the LRG. <;P>;SOLUTION: This LRG is firstly recognized to have a neovascularization-inducing function by the earnest research of function of the LRG. Thus, the neovascularization-inducing molecule comprising the LRG, a new vascularization-inducing agent containing the vascularization-inducing molecule as an active ingredient, and a new neovascularization induction inhibitor by taking the neovascularization-inducing molecule as a target are provided. <;P>;COPYRIGHT: (C)2011,JPO&INPIT